Aegerion Pharmaceuticals, Inc. 4
4 · Aegerion Pharmaceuticals, Inc. · Filed Aug 6, 2015
Insider Transaction Report
Form 4
Andrews William T.
See Remarks
Transactions
- Award
Stock Option (right to buy)
2015-08-04+40,000→ 40,000 totalExercise: $19.52Exp: 2025-08-04→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]The stock option award was made to the Reporting Person as part of a retention arrangement approved by the Issuer's Board of Directors on August 4, 2015.
- [F2]The stock option award has an exercise price equal to the fair market value of the closing price of the Issuer on the date of the grant.
- [F3]25% of the shares of common stock underlying this stock option award will vest on August 4, 2016. The remaining 75% of the shares of common stock underlying this stock option award will vest thereafter in equal monthly installments through August 4, 2019, subject to the Reporting Person's continued employment with the Issuer.